These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2759347)

  • 1. Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.
    Vincent-Falquet JC; Peyron L; Souvras M; Moulin JC; Tektoff J; Patet J
    Dev Biol Stand; 1989; 70():153-6. PubMed ID: 2759347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.
    Montagnon BJ
    Dev Biol Stand; 1989; 70():27-47. PubMed ID: 2759353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with vero cells at Pasteur Mérieux Connaught.
    Montagnon BJ; Vincent-Falquet JC; Saluzzo JF
    Dev Biol Stand; 1999; 98():137-40; discussion 167. PubMed ID: 10494966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with the Vero cell line.
    Montagnon BJ; Vincent-Falquet JC
    Dev Biol Stand; 1998; 93():119-23. PubMed ID: 9737386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
    Zhang DL; Ji L; Li LJ; Huang GS
    Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
    Sureau P; Perrin P; Horaud F
    Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
    Lang J; Feroldi E; Vien NC
    J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ; Fanget B; Nicolas AJ
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
    Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
    Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated polio vaccine: industrial production from micro-carrier Vero cells culture.
    Montagnon BJ
    Trop Geogr Med; 1985 Sep; 37(3):S40-1. PubMed ID: 4071633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.
    Audet SA; Crim RL; Beeler J
    Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.